| scholarly article | Q13442814 |
| P2093 | author name string | Byrne DW | |
| Wood AJ | |||
| Stein CM | |||
| Kim RB | |||
| Xie HG | |||
| Sofowora GG | |||
| Dishy V | |||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1030-1035 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization | |
| P478 | volume | 345 |
| Q33933952 | A high-fat meal impairs muscle vasodilatation response to mental stress in humans with Glu27 beta2-adrenoceptor polymorphism |
| Q36579644 | A simple and rapid genotyping assay for simultaneous detection of two ADRB2 allelic variants using fluorescence resonance energy transfer probes and melting curve analysis |
| Q39844001 | A46G and C79G polymorphisms in the β2-adrenergic receptor gene (ADRB2) and essential hypertension risk: a meta-analysis |
| Q34351256 | ADRB2 gene variants, dual-energy x-ray absorptiometry body composition, and hypertension in Tobago men of African descent |
| Q35825884 | Acute systemic effects of inhaled salbutamol in asthmatic subjects expressing common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27 |
| Q34981129 | Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy |
| Q33568524 | Adrenergic-beta(2) receptor polymorphism and athletic performance |
| Q35073471 | Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications |
| Q47110895 | Alveolar air and oxidative metabolic demand during exercise in healthy adults: the role of single-nucleotide polymorphisms of the β2AR gene |
| Q44645586 | Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia |
| Q46580554 | Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise |
| Q46843780 | Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans |
| Q51427854 | Arg16Gly β2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease. |
| Q45292671 | Arg347Cys polymorphism of alpha1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients |
| Q36237969 | Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol |
| Q51029544 | Association of the ADRB2 Gly16Arg and Glu27Gln polymorphisms with athlete status. |
| Q53781837 | Association of β-Adrenergic Receptor Gene Polymorphisms With Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population. |
| Q33869152 | Association study of the β2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han Chinese |
| Q35683221 | Benefit-risk assessment of long-acting beta2-agonists in asthma |
| Q34658477 | Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases |
| Q28204128 | Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies |
| Q44278243 | Beta(2)-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans |
| Q33907401 | Beta-2 adrenoceptor genotype and progress in term and late preterm active labor |
| Q54380413 | Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans. |
| Q40549499 | Beta-adrenergic receptor polymorphism in human cardiovascular disease |
| Q36442614 | Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors |
| Q34612106 | Beta-adrenergic receptor polymorphisms and drug responses in asthma |
| Q35043482 | Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics |
| Q38745611 | Beta-adrenergic signaling promotes tumor angiogenesis and prostate cancer progression through HDAC2-mediated suppression of thrombospondin-1. |
| Q35597242 | Beta-adrenoceptor polymorphisms |
| Q33778169 | Beta-blocker pharmacogenetics in heart failure |
| Q37114101 | Beta1- and beta2-adrenoceptor polymorphisms and cardiovascular diseases |
| Q59049500 | Beta2-Adrenergic Receptor Gene Polymorphisms in Egyptian Patients with Acute Myocardial Infarction |
| Q33994355 | Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern |
| Q51934185 | Beta2-adrenergic receptor polymorphisms are associated with asthma and COPD in adults. |
| Q46565006 | Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma |
| Q57293266 | Cardiovascular Pharmacogenomics: Does It Matter If You're Black or White? |
| Q35621396 | Challenges of implementing pharmacogenetics in the critical care environment |
| Q35204078 | Clinical implications of pharmacogenetics for glaucoma therapeutics |
| Q33900908 | Clustering heart rate dynamics is associated with β-adrenergic receptor polymorphisms: analysis by information-based similarity index |
| Q53089336 | Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study. |
| Q35536841 | Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol |
| Q44899940 | D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients |
| Q33955008 | Desensitization of vascular response in vivo: contribution of genetic variation in the [alpha]2B-adrenergic receptor subtype. |
| Q90102159 | Differential Dynamics Underlying the Gln27Glu Population Variant of the β2-Adrenergic Receptor |
| Q37282807 | Differential desensitization of homozygous haplotypes of the beta2-adrenergic receptor in lymphocytes |
| Q25255837 | Differential susceptibility to hypertension is due to selection during the out-of-Africa expansion |
| Q34072541 | Effects of β2-adrenergic receptor gene polymorphisms on ritodrine therapy in pregnant women with preterm labor: prospective follow-up study |
| Q47835884 | Evolutionary divergence of thyrotropin receptor structure |
| Q51483942 | Exercise capacity after coarctation repair relates to the c.46A > G genomic polymorphism of the ss2-adrenoreceptor and the c.704T > C angiotensinogen polymorphism. |
| Q34124219 | False positive non-synonymous polymorphisms of G-protein coupled receptor genes |
| Q45272416 | Functional adrenergic receptor polymorphisms and idiopathic orthostatic intolerance |
| Q48032422 | G16R single nucleotide polymorphism but not haplotypes of the β(2)-adrenergic receptor gene alters cardiac output in humans |
| Q37117267 | GENETIC VARIATION IN THE β(2)-ADRENERGIC RECEPTOR: IMPACT ON INTERMEDIATE CARDIOVASCULAR PHENOTYPES |
| Q51025427 | Genetic determination of the vascular reactions in humans in response to the diving reflex. |
| Q36375432 | Genetic polymorphisms of pharmacogenomic VIP variants in the lhoba population of southwest China |
| Q38099580 | Genetic prediction of heart failure incidence, prognosis and beta-blocker response |
| Q35658737 | Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise. |
| Q51920852 | Genetic variation of the beta2-adrenergic receptor is associated with differences in lung fluid accumulation in humans. |
| Q37067189 | Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans |
| Q34827577 | Genetic variations in the α(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine |
| Q34581642 | Genetics and cardiovascular system: influence of human genetic variants on vascular function |
| Q36947426 | Genetics and pharmacogenetics in heart failure |
| Q37117485 | Genetics of beta2-adrenergic receptors and the cardiopulmonary response to exercise |
| Q37513040 | Has pharmacogenetics brought us closer to 'personalized medicine' for initial drug treatment of hypertension? |
| Q37854508 | Heart failure pharmacogenetics: past, present, and future |
| Q47313325 | Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. |
| Q35102211 | Implications of pharmacogenetics for individualizing drug treatment and for study design |
| Q24296507 | Increased enzyme activity and beta-adrenergic mediated vasodilation in subjects expressing a single-nucleotide variant of human adenylyl cyclase 6 |
| Q28385491 | Independent regulation of α1 and α2 adrenergic receptor-mediated vasoconstriction in vivo |
| Q46796691 | Influence of beta(2)-adrenoceptor gene polymorphisms on diet-induced thermogenesis. |
| Q46865801 | Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis |
| Q50620619 | Interactions between beta-2 adrenoceptor gene variation, cardiovascular control and dietary sodium in healthy young adults. |
| Q28290776 | Interethnic differences in drug response: the contribution of genetic variability in beta adrenergic receptor and cytochrome P4502C9 |
| Q46402418 | Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease |
| Q28481719 | Mapping genetic variants associated with beta-adrenergic responses in inbred mice |
| Q64103561 | Neurally mediated syncope diagnosis based on adenylate cyclase activity in Japanese patients |
| Q36290281 | Neurovascular control during exercise in acute coronary syndrome patients with Gln27Glu polymorphism of β2-adrenergic receptor. |
| Q34753720 | Nitric oxide-mediated vasodilation becomes independent of beta-adrenergic receptor activation with increased intensity of hypoxic exercise |
| Q41821185 | Nuclear factor kappa B and matrix metalloproteinase induced receptor cleavage in the spontaneously hypertensive rat. |
| Q37938905 | Overview of pharmacogenetics |
| Q38214388 | Pharmacogenetic biomarkers for predicting drug response. |
| Q26859221 | Pharmacogenetics and anaesthesia: the value of genetic profiling |
| Q36478845 | Pharmacogenetics approach to therapeutics |
| Q35590351 | Pharmacogenetics goes genomic |
| Q35038056 | Pharmacogenetics in drug development |
| Q33776918 | Pharmacogenetics of antihypertensive treatment: detailing disciplinary dissonance |
| Q36645472 | Pharmacogenetics of beta2-agonist drugs in asthma |
| Q36459142 | Pharmacogenetics of the human beta-adrenergic receptors |
| Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
| Q35956177 | Pharmacogenetics-based new therapeutic concepts |
| Q35164676 | Pharmacogenomic considerations in drug delivery |
| Q28171051 | Pharmacogenomics and drug response in cardiovascular disorders |
| Q35911140 | Pharmacogenomics of adrenoceptors. |
| Q35106506 | Pharmacogenomics of congestive heart failure |
| Q35090217 | Pharmacogenomics: marshalling the human genome to individualise drug therapy |
| Q34976915 | Pharmacogenomics: the genetics of variable drug responses |
| Q34726091 | Physicians' interpretation of "class effects": a need for thoughtful re-evaluation |
| Q35776631 | Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives |
| Q38827323 | Practical Pharmacogenomic Approaches to Heart Failure Therapeutics |
| Q35693323 | Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology |
| Q33796356 | Reciprocal regulation of endocytosis and metabolism |
| Q33880949 | Relationship between polymorphisms in beta -2 adrenergic receptor gene and ischemic stroke in North Indian Population: a hospital based case control study |
| Q34974804 | Relationships of adrenoceptor polymorphisms with obesity |
| Q44362842 | Reproducibility of dorsal hand vein responses to phenylephrine and prostaglandin F2 alpha using the dorsal hand vein compliance method. |
| Q37044831 | Role of beta adrenergic receptor polymorphisms in heart failure: systematic review and meta-analysis |
| Q34235779 | Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome |
| Q33521568 | Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database |
| Q44686530 | The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise |
| Q83853960 | The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans |
| Q44458675 | The Arg16Gly-β2-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure |
| Q41453514 | The Gly16 Allele of the G16R Single Nucleotide Polymorphism in the β 2 -Adrenergic Receptor Gene Augments the Glycemic Response to Adrenaline in Humans |
| Q42817034 | The Gordon Wilson Lecture: neurohormonal signaling pathways that link cardiac growth and death. |
| Q35825894 | The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol |
| Q35868184 | The association of beta-2 adrenoceptor genotype with short-cervix mediated preterm birth: a case-control study |
| Q47280550 | The effect of beta-2 adrenergic receptor haplotype variations on the haemodynamic response following spinal anaesthesia for caesarean delivery. |
| Q35009810 | The effect of maternal and fetal β2-adrenoceptor and nitric oxide synthase genotype on vasopressor requirement and fetal acid-base status during spinal anesthesia for cesarean delivery |
| Q35980603 | The emerging pharmacogenomics of the beta-adrenergic receptors |
| Q46755077 | The impact of beta-adrenoreceptor gene polymorphisms on survival in patients with congestive heart failure |
| Q39303486 | The intensive care medicine research agenda on septic shock |
| Q37343578 | The pharmacogenetics of asthma treatment |
| Q34994884 | Very important pharmacogene summary ADRB2. |
| Q46607151 | beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. |
| Q37175268 | beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension |
| Q43256385 | beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock |
| Q48321102 | beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort |
| Q43046169 | beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade |
| Q34659889 | {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype |
| Q35767880 | β-2 Adrenergic receptor gene polymorphism and response to propranolol in cirrhosis |
| Q34766294 | β2 adrenergic receptor polymorphisms and nocturnal blood pressure dipping status in the Wisconsin Sleep Cohort Study |
| Q43969385 | β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients |
Search more.